Evidence map›Paper›PMID 37605416›Full record

ReviewCombinatorial chemistry & high throughput screening2024

Expanded Therapeutic Applications of

Ruchi Tiwari, Charul Khatri, Lalit Kumar Tyagi, Gaurav Tiwari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Combinatorial chemistry & high throughput screening, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Frontiers in pharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruchi TiwariPSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, 208020, India.
Charul KhatriPSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, 208020, India.
Lalit Kumar TyagiLloyd Institute of Management and Technology, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306, India.
Gaurav TiwariPSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, 208020, India.ORCID 0000-0003-2200-737X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of medicinal plants as a rich resource of therapeutic agents in the treatment and prevention of diseases & ailments has been recognized for millennia and is highly regarded worldwide.

objectiveThe study concentrated on aggregate information regarding

methodsRegardless of its broad variety of biological and possible therapeutic uses, there has been increasing concern regarding the use of

resultVarious phytochemicals have been extracted from

conclusionThis review paper investigated the in-depth description and pharmacological properties of the plant, which produced significant findings on the chemical components present and also verified the traditionally claimed properties associated with the plant.

Indexed as

HolarrhenaPlant ExtractsAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsHumansHypoglycemic AgentsPhytochemicalsPlants, MedicinalSeedsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsHypoglycemic AgentsPhytochemicalsPlant Extractsantibacterial activity.antidiabetic activityanti-diarrheal activityantioxidant activityH. antidysentericatherapeutic applications

Identifiers

PMID37605416
OpenAlexW4386046669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.